Basic Information
RosVivo Therapeutics, Inc. is a Nevada-based miRNA new drug development company. RosVivo's new drug RSVI-301 for diabetes also utilizes miRNA. Composed of 20-24 nucleotides, miRNA is referred to as a "small vacuum cleaner" in the body, naturally regulating the metabolic processes of genes and proteins.
RosVivo Therapeutics, Inc.
Nevada,United States of America
unclear
February 19, 2021
sro@rosvivo.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios